化学
生物物理学
小泡
膜
细菌外膜
纳米技术
脂泡
细胞生物学
细胞膜
低温电子显微
材料科学
作者
Feifei Zhang,Zhencun Cui,Haidong Li,Weicai Li,Chuanxi Wen,Junqiang Dai,Yumin Wu,Wangsuo Wu,Zhuang Liu,Longlong Tian
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-06-09
卷期号:20 (24): 17501-17517
被引量:1
标识
DOI:10.1021/acsnano.6c03796
摘要
Combining targeted radionuclide therapy (TRT) with immunotherapy offers a potent strategy to amplify antitumor immunity, yet the development of adaptable delivery platforms remains a challenge. Herein, we report a programmable, “plug-and-play” nanoplatform, termed TRT@LnOMVs, engineered for synergistic radio-immunotherapy. By displaying lanmodulin (LanM) on the surface of outer membrane vesicles (OMVs)-derived from attenuated Salmonella typhimurium, this platform enables the versatile and high-efficiency radiolabeling of diverse therapeutic radioisotopes under mild conditions, circumventing the limitations of conventional chelator-based methods. The platform’s modularity is further demonstrated by the facile incorporation of lipid-conjugated ligands for precision targeting. In a head-to-head comparison with clinically approved 177 Lu-PSMA-617 (Pluvicto), PSMA-targeted TRT@LnOMVs achieved a 90% survival rate in a prostate cancer model, far surpassing the 25% survival rate of Pluvicto. Single-cell RNA sequencing and transcriptomic analysis revealed that TRT@LnOMVs significantly remodeled the tumor immune microenvironment. This occurred through reprogramming immunosuppressive myeloid compartments (including neutrophil subsets and macrophages), expanding cytotoxic CD8 + T and NK cell infiltration, and activating innate immunity to trigger robust antitumor responses. Collectively, TRT@LnOMVs represent a versatile class of biohybrid therapeutics, offering a robust paradigm for next-generation radio-immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI